Clinical Trial Update: A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants [Phase 1]

View source ↗

Summary

A Phase 1 study assessed the relative bioavailability of subcutaneous bepirovirsen when administered from a vial versus a prefilled syringe with a safety syring…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Bepirovirsen

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 1 | Status: COMPLETED | Results posted: 2025-07-18